Corrigendum to "Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy" [Epilepsy Res. (2023) 191 107112].
第一作者:
Joseph,Sullivan
第一单位:
University of California San Francisco Weill Institute for Neurosciences, Benioff Children's Hospital, San Francisco, CA, USA.
作者:
DOI
10.1016/j.eplepsyres.2024.107342
PMID
38480083
发布时间
2024-06-06
- 浏览0
Epilepsy research
107342页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



